DIGITAL-VAULT-SERVICES
Clearstream, Deutsche Börse’s post-trade business, intends to make an investment in Digital Vault Services (DVS), a pioneering fintech offering issuance and safekeeping services for digital bank guarantees and sureties in Europe. The investment is subject to applicable regulatory approvals and finalisation of legal documentation.
The investment enables DVS to further enhance and broaden its offering as a market infrastructure solution for corporates and financial institutions. The mid-term plan will be to integrate DVS’s Guarantee Vault with D7, the digital post-trade platform of Deutsche Börse and its post-trade business Clearstream. This will allow D7 for the first time to expand its digital asset product portfolio to non-securities.
With DVS’s established offering in Europe coupled with Clearstream’s leverage and experience offering market infrastructure solutions and connectivity, both parties seek to bring added value to the trade finance ecosystem of corporates, banks and insurers.
Jens Hachmeister, Head of Issuer Services & New Digital Markets at Clearstream, said: “Digital leadership is a central part of Deutsche Börse Group’s Horizon 2026 strategy. The companies’ shared commitment to market innovation makes DVS a perfect fit for Deutsche Börse and Clearstream. We are convinced that DVS’s innovative approach to digital bank guarantees, combined with D7’s track record in digitising securities and Clearstream’s central role in global financial markets, will drive significant growth and deliver value for our clients and ultimately the entire financial industry.”
Ludger Janssen, Co-CEO of Digital Vault Services, added: “Clearstream has emerged as a strategic ally for DVS, echoing our dedication to streamlining processes and recognizing the transformative potential of digitisation in the financial industry, in particular with regards to guarantee management. With technology as our foundation, together with Clearstream and our central and digital guarantee registry, we foresee a unique end-to-end solution that disrupts and modernises outdated procedures with unparalleled efficiency.”
Jaime Gimeno, Co-CEO of Digital Vault Services, added: “Back in 2018, when designing a solution to the cumbersome paper-based process for issuing and storing guarantees, we took inspiration from the central securities depository model used in the securities industry. This strategic partnership with Clearstream now represents a major milestone in our growth journey towards becoming the recognized market infrastructure solution for guarantees in Europe. As we move forward the partnership also positions DVS for exciting new use cases and instruments.”
The investment will be done in exchange for a minority stake and is expected to be completed in H2/2024, subject to applicable regulatory approvals and finalisation of legal documentation.
Digitising financial markets
Today’s financial markets are highly fragmented with isolated technology solutions, resulting in slow processes, high error rates and costs for all market participants. Digital solutions aim to counter these problems by connecting networks and market players across system boundaries, thereby boosting transparency, process efficiency and technology interoperability.
Deutsche Börse and its post-trade business Clearstream provide with their digital post-trade platform D7 a fully digital alternative to conventional physical issuance and managing of financial securities, reducing the time-to-market for securities from days to minutes.
With its Guarantee Vaults product, DVS provides a digital solution allowing corporates to centrally issue and store bank guarantees that are required across different segments as industry standard.
[Editorial note: Please find here a high-resolution photo of Jens Hachmeister.]
About Clearstream
Clearstream is the innovative and trusted post-trade business for the global markets. It runs the leading securities and funds servicing ecosystems of tomorrow. The company operates the German and Luxembourg central securities depositories and an international central securities depository for the Eurobonds market. With 18 trillion Euros in assets under custody, it is one of the world’s largest settlement and custody firms for domestic and international securities.
It also delivers premier fund execution, distribution, data and reporting services, covering over 55 fund markets worldwide. Clearstream is part of Deutsche Börse Group, an international exchange organisation and provider of innovative market infrastructures.
To learn more, visit us at www.clearstream.com or connect via LinkedIn.
About Digital Vault Services
The idea for Digital Vault Services emerged in 2017 from the needs of the Treasury department of Lindner Group KG, Arnstorf, Germany. A strong working group of corporates and financial institutions from across Europe then came together to design a market solution to a common problem around the paper-based guarantee process. Since then, Digital Vault Services has rapidly evolved, gaining strong traction in DACH and now expanding into other European markets including the Nordics. Headquartered in Munich, Germany, Digital Vault Services is at the forefront of guarantee digitisation. The current shareholders, being Lindner Group KG and Management, now welcome Deutsche Börse to join them on the exciting journey ahead.
Visit us at www.digitalvaultservices.com or connect via LinkedIn to get to know more about Digital Vault Services and Guarantee Vault.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240417214758/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
